〔病案報導〕
免疫達和免疫二號聯合運用治療膀胱癌一例
美國 柯明煌
The patient, female, 79
years old, was diagnosed as having bladder carcinoma of grade II, III by biopsy
report. Recurrence occurred several times after surgeries that were carried out
every 3 months in 2 years. The patient was significantly emaciated. Herbal
medicine Immune Up ® and Immuny II ® were applied since Nov. 1997. A biopsy
test one month later showed improvement. Ten months later, the biopsy test
showed the tumor had turned to be benign. The follow up examination every 3
months from January to July 1999 after that proved this finding.
The relevant biopsy
reports are attached here after.
Ingredients of IMMUNE
UP®:
Rehmannia Root,
American Cranesbill Root, Polygonatum Rhizome, American Loquat Seed, Loquat
Leaf, Ginger Root, Lycium Berry, Epimedium, Cinnamon Bark, Flowery Knotweed
Root, Atactylodes Ovata Rhizome, Astragalus Root, Codonopsis Root, Licorice
Root.
Ingredients of IMMUNY
II®:
Angelica Sinensis
Root, Tuhuo Angelica Root, Fritillaria Bulb, Forsythia Fruit, Fermented
Pinellia Tuber, Sargassum, Laminaria, Citrus Peel, Ligusticum Rhizome,
Tangerine Peel, Rehannia Root, White Peony Root, Codonopsis Root, Atractylodes
Ovata Rhizome, Poria Core, Astragalus Root, Cinnamon Bark, Schisandra Fruit,
Polygala Root, Ginger Root, Chinese Date, Licorice Root.
女性病人,七十九歲,因血尿經病理檢查診斷為晚期膀胱癌。曾採用手術切除法治療,在兩年中,每三個月就切除一次,但每次切除後均有再生,且病人健康狀況日漸惡化。病理檢查結果均屬惡性。
兩年後改用草藥新劑型Newvita®的免疫達®及免疫二號®並用治療,一個月後病理檢查報告顯示有所進步,服藥十個月後,腫瘤已由惡性轉變為良性。以後每三個月例行檢查一次,一九九九年一月、四月及七月的檢查結果均未見癌細胞。
以下為相關的病理檢驗報告。
Summary of Pathological Reports
Patient’s
Name: K. W. C., 72, F. Diagnosis: Bladder Cancer Test Item: Biopsy for the mass
Before
taking Immune Up® and Immuny II® |
After
taking Immune Up ® and Immuny II® Since
11/30/97 |
||
3-6-97 |
9-8-97 |
12-29-97 |
9-3-98 |
A.
Left posterior wall: papillary urothelial carcinoma, Grade III, with focal
invasion of the Lamina Propria, amid intersely inflamed granulation tissue,
Deep smooth muscle is present in this biopsy, negative for tumor. B.
Bladder tumor midline base: Papillary
urothelial carcinoma Grade II. No stromal invasion seen. Deep smooth muscle
is not present in this biopsy. Signature
on file Tao-Tseng
Chen, M.D., Pathologist |
A.
Left bladder neck: Papillary transitional cell carcinoma, Grade II-III,
noninvasive, see note. Note:
The Tissue is extensively cauterized and subcptimally oriented Muscularis
propria is not present for evaluation. Signature
on file Robert
A. Soslow, M.D., Pathologist. |
A.
Floor of bladder: Bundles of muscular aris propria. Rare detached fragments
of inflamed adipose tissue are identified. Minute fragments of detached
urotbelial mucosa are also identified. There are no evidence of a neoplastic
process in this biopsy specimen. B.
Posterior wall bladder: Papillary urothelial (transitional cell) carcinoma,
(cf S97-5933). Grade II, noninvasive. Muscularis
proprial is present in this biopsy. There is mild chronic cystitis underlying
the neoplastic process. C.
Dome: Filbroconnective
tissue, exhibiting considerable crush artifact process is identified. Signature
on file Syed
A. Hoda, M .D., Pathologist |
A.
Bladder biopsy posterior Wall: Granulomatous chronic cystitis. Urothelium is
almost completely denuded. Smooth muscle present. No tumor seen. B.
Bladder biopsy, left bladder wall: Granulomatous chronic cystitis. Portions
of intact Urothelium are free of atypia. Smooth muscle present. No tumor
seen. C.
Bladder biopsy, dome: Granulomatous chronic cystitis. Urothelium is free of
atypia. Smooth muscle present. No tumor seen. Signature
on file Mark
A. Edgar, Pathologist. |
洽詢地址Add.: 2712
San Gabriel Boulevard
Rosemead, CA 91770 U.S.A.
電話Tel.: (626)
288-1199
傳真Fax: (626)
288-4199